Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial. Read more about Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial.
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction. Read more about A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study. Read more about Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study.
Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4. Read more about Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4.
Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Read more about Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study.
Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB. Read more about Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.
Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort. Read more about Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort.
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Read more about Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.
A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations. Read more about A modified Hospital Frailty Risk Score for patients with cirrhosis undergoing abdominal operations.
Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis. Read more about Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis.
